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Primary Vaccination of Indian Infants at 6, 10, 14 Weeks
of Age with a Diphtheria, Tetanus, Acellular Pertussis,
Inactivated Poliovirus, Haemophilus Inﬂuenzae Type B
Conjugate Vaccine (Pentaxim)
A.K. Dutta1,∗, V.P. Verghese2, E. Ortiz3
1 LHMC & Associated Hospitals, New Delhi, India
2 Christian Medical College Hospital, Vellore, India
3 Sanoﬁ Pasteur, Lyon, France
Background: Data on the immunogenicity and safety of
acellular pertussis-based combination vaccines when given
in the WHO recommended EPI schedule (6, 10 and 14 weeks
of age) are needed for making individual clinical practice
and public policy decisions in India.
Methods: This study assessed the immunogenicity and
safety of primary vaccination at 6, 10 and 14 weeks of
age with PentaximTM (sanoﬁ pasteur, AcXim family vaccine)
including diphtheria, tetanus, acellular pertussis, inacti-
vated poliovirus, Haemophilus inﬂuenzae type b conjugate
(PRP-T)antigens in 226 infants in India. Antibody titers were
measured immediately before, and one month after, pri-
mary vaccination. Immunogenicity data from French infants
vaccinated at 2, 3 and 4 months was used as a reference.
Reactogenicity and safety were evaluated from parental
reports.
Results: One month after the third dose, 90.0% of sub-
jects had anti-PRP≥ 1.0g/mL, and the GMT increased
from 0.11g/mL to 4.17g/mL. Anti-Polio GMTs (1/dil U)
increased from 18.1 to 441, from 20.4 to 459, and from 9.9
to 1511 for types 1, 2 and 3, respectively. Two-fold increase
in PT and FHA antibody concentration occurred in 97.1%
and 92.4% of subjects, and anti-PT and anti-FHA antibody
titers≥ 25 EU/mL were observed in 100% and 97.6% of chil-
dren, respectively. The vaccine was well-tolerated, with low
reactogenicity. Severe solicited reactions were documented
in < 0.5% of subjects after any dose. No drop outs occurred
because of adverse events.
Conclusion: Pentaxim given at 6, 10 and 14 weeks of age
was well tolerated and induced large immune responses in
Indian infants, similar to those observed in French infants




Immunogenicity and Safety of Human Papillomavirus
(HPV)-16/18 AS04 Adjuvanted Vaccine in Healthy Males
Aged 10—18 Years
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Background: A human papillomavirus (HPV) 16/18 AS04
adjuvanted vaccine (CervarixTM, GlaxoSmithKline) has been
shown to be well-tolerated and immunogenic in females
aged 10—55 years, and effective for the prevention of HPV-
16/18 infections and associated precancerous lesions in
15—25 year-old women. Our study evaluated the immuno-
genicity and safety of CervarixTM in 10—18 year-old healthy
males.
Methods: This was a phase I/II, observer-blind, parallel-
group study (580299/011/NCT00309166). Males were ran-
domized (2:1 ratio) to receive CervarixTM (n = 181) or
hepatitis B vaccine (Engerix-BTM, GlaxoSmithKline) (n = 89)
at 0, 1 and 6 months and were followed for 7 months after
the ﬁrst dose.
Results: At Month 2, 100% of seronegative males in the
HPV group had seroconverted for HPV-16 and 18 (ELISA) and
remained seropositive at Month 7. At this time point, GMTs
were respectively 4-fold and 2-fold higher, as compared to
Month 2. The immune response to CervarixTM in 10-18 year-
old males was non-inferior for both seroconversion rates and
GMTs to that seen in 15—25 year-old females in a previous
study. The reactogenicity proﬁle of the vaccine in males was
similar to that reported in females. Compliance with 3-dose
course was equally high (97%) in both groups.
Conclusion: CervarixTM is immunogenic and well-
tolerated in 10—18 year-old males, inducing anti-HPV-16
and 18 antibody responses non-inferior to those previously
reported in 15—25 year-old females, among whom efﬁcacy
has been previously demonstrated. However, whether vac-
cination of adolescent males will ultimately prevent sexual
transmission of oncogenic HPV types or have public health
value remains to be determined.
doi:10.1016/j.ijid.2008.05.434
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Modulation of Interleukin-18 Produces a Positive Impact
on the Release of Proinﬂammatory and Antiinﬂammatory
Cytokines During Malaria Infection
R. Basir 1,∗, K. Hasballah2, L.H. Gam2, A.M.S. Abdul Majid2,
S. Ismail 2
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Malaria infection is associated with the release of proin-
ﬂammatory cytokines including TNF-alpha, IFN-gamma,
IL-1, and IL-6. These cytokines play important roles in medi-
ating the disease severity and involved in the pathogenesis
and immunopathological reactions during the infection.
IL-18 is a potent pro-inﬂammatory cytokine and inducer
of other cytokines release. In this study, we investigated the
effect of modulating IL-18 production on the release of pro-
inﬂammatory and anti-inﬂammatory cytokines (TNF-alpha,
IFN-gamma, IL-1, IL-6 and IL-10) during malaria infection.
Plasmodium berghei infection in ICR mice was used as
model for malaria infection. Mice were inoculated with par-
asitized red blood cells from donor mouse infected with
P. berghei. Control animals received normal uninfected
red blood cells. IL-18 production during the infection was
modulated by treatment with the rIL-18, rIL-18 binding
protein and anti-IL-18 monoclonal antibody. Blood samples
for plasma were collected from the animals on day 1, 3
and 5 following inoculation and treatment. ELISA method
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was employed to measure the levels of cytokines in the
plasma.
IL-18 level in the plasma of malarial mice were found
to be signiﬁcantly elevated and positively correlated with
the percentage degree of parasitaemia. Inhibition and neu-
tralization of IL-18 production caused signiﬁcant decrease in
the plasma levels of pro-inﬂammatory cytokines TNF-alpha,
IFN-gamma, IL-1 and IL-6. In contrast, the anti-inﬂammatory
cytokine IL-10 was signiﬁcantly increased. Treatment with
rIL-18 on the other hand caused signiﬁcant increase in
pro-inﬂammatory cytokines plasma levels, whereas the anti-
inﬂammatory cytokine level was signiﬁcantly reduced.
Results proved the involvement of IL-18 in malaria infec-
tion. Its positive modulatory effects on the release of
pro-inﬂammatory and anti-inﬂammatory cytokines during
the infection may suggest its crucial role(s) in the pathogen-
esis of the infection. Results also suggest the IL-18 potential
as an immunotherapeutic target in malaria therapy.
doi:10.1016/j.ijid.2008.05.435
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Construction and Functional Evaluation of rtxC and rtxA/C
Mutants of O139 Vibrio cholerae
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The diarrheal cholera is caused by Vibrio cholerae which
colonizes the mucosal epithelium lining of small intestine
and secretes cholera toxin (CT). Besides CT, several other
accessory toxins like RTX, HA/protease also contributed to
the reactogenicity of the disease. The RTX toxin is a mul-
tifunctional protein which causes rounding of host cells
through Rho-GTPase inactivation and covalent cross-linking
of actin. The toxin is encoded by rtxA gene which resides
within RTX gene cluster, while rtxC gene codes for acyltrans-
ferase, activator for RTX toxin. Thus, the present study was
carried out to mutate the rtxA/C gene in O139 V. cholerae
and study virulence properties of the mutants. The colo-
nization ability and ﬂuid accumulation were done in animal
models. While the effect of RTX toxin was tested by rounding
assay using HEp-2 cell line. The formation of actin cross-
linking to dimers, trimers and higher multimer were studied
by Western blot analysis. The rtxA/C mutants were con-
structed by allele replacement method and were named as
VCUSM9P (rtxC::aphA) and VCUSM10P (rtxA/C). The muta-
tions were conﬁrmed by PCR and DNA sequencing. The RTX
mutants colonized equally well in infant mouse as com-
pared to the WT. Fluid accumulation elicited by RTX mutants
were same as the WT but without haemorrhage. Rounding
effect on HEp-2 cells was not observed in RTX mutants as
compare with WT. But Western blot analysis showed that
VCUSM9P still retained residual activity of RTX toxin, as actin
multimer bands were detected. Actin multimer bands were
not detected in VCUSM10P infected HEp-2 cells. Our ﬁnd-
ing shows that mutation of rtxC alone does not completely
eliminate RTX toxicity, but mutation of rtxA and rtxC gene
completely eliminate RTX toxicity. In conclusion, we have
constructed an O139 RTX mutant strains which has good col-
onizing ability though it is reactogenic due to the presence
of intact ctx operon.
doi:10.1016/j.ijid.2008.05.436
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Hepatitis C Virus Infection Protein Network
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Rabourdin-Combe, V. Lotteau
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Replication of Hepatitis C virus (HCV) relies on multiple
interactions with host factors but how these interactions
determine infection, sensitivity to treatment and patho-
genesis remain largely undeﬁned. In a ﬁrst attempt to
provide a comprehensive view of a cellular infection by HCV,
we present here a proteome-wide mapping of interactions
between HCV and human cellular proteins. This interaction
map was ﬁrst generated by stringent high-throughput yeast
two-hybrid (Y2H) screening, using both full-length HCV pro-
teins and domains as baits. This map was then completed
by an extensive mining of the literature. A total of 314
pairwise interactions between HCV and human proteins was
identiﬁed by Y2H, and 170 by literature mining. The entire
dataset was integrated into a reconstructed human interac-
tome composed of 9,520 proteins and 44,223 interactions.
The topological analysis of this network indicated that cel-
lular proteins interacting with HCV are enriched in highly
central and interconnected proteins, suggesting that HCV
preferentially targets proteins with essential functions. A
global analysis of these proteins based on functional anno-
tation showed a highly signiﬁcant enrichment for cellular
pathways related to pathogenesis. A network comprising
proteins associated to frequent clinical disorders of chron-
ically infected patients was constructed by connecting the
insulin, Jak/STAT and TGF-beta pathways with cellular pro-
teins targeted by HCV. CORE protein appeared as a major
perturbator of this network. The focal adhesion was also
identiﬁed as a new function affected by the virus, mainly by
NS3 and NS5A proteins.
doi:10.1016/j.ijid.2008.05.437
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Identiﬁcation of Candida tropicalis Immunoreactive Pro-
teins by Immunoproteomics
V.C. Yong ∗, R. Rozita, H.F. Seow, P.P. Chong
Universiti Putra Malaysia, Serdang, Malaysia
Candida tropicalis is the most commonly isolated species
found in systemic candidiasis and could have greater vir-
ulence than other Candida species. The transition from
a commensal to a pathogen may be due to its ability to
change its cellular morphology, adhesion factors, pheno-
typic switching and extracellular proteolytic activity. Thus,
to further elucidate the involvement of Candida tropicalis
proteins in pathogenesis, we generated systemic candidia-
